Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
A buy recommendation
In a nut shell, I saw Butterfly Network as a medical break through and bought a few hundred shares at a $1.55/shr. and the following news confirmed my reasoning of buying; On November 17, 2025, Butterfly Network’s subsidiary signed a five-year co-development and licensing agreement with Midjourney for exclusive access to its semiconductor-based ultrasound technology, securing a US$15 million upfront payment, US$10 million annual license fees, and further milestone and revenue-sharing potential.Read more
SLI is share to watch next 5 years
Assumptions Where do you think revenue will be in 5 years time? and why?Read more
Growing between 25-50% for the next 3-5 years
When I look at an investment, I look for more than just numbers—I look for a story of impact, scalability, and sustainability. Optasia is that story.Read more
GE Vernova revenue will grow by 13% with a future PE of 64.7x
Revenue Growth : GE Vernova is expected to grow its revenue by 13% , contributing to a total revenue of US$77 billion. Earnings Forecast : Estimated earnings for 2030 are US$4.2 billion , translating into a market capitalization of US$270.06 billion , based on a 64.68x price-to-earnings ratio.Read more
The "Molecular Pencil": Why Beam's Technology is Built to Win
The "Molecular Pencil": Why Beam's Technology is Built to Win The investment thesis in Beam Therapeutics is a long-term, high-conviction bet on a fundamental technological shift in genetic medicine. While first-generation gene editors like CRISPR-Cas9 function as "molecular scissors," they are an inherently disruptive tool.Read more
Estimated Share Price is $79.54 using the Buffett Value Calculation
Using the Buffett Value Calculation with P/E = $46.02, Growth Rate = 39.18%, and EPS ttm = $0.55 (source: FinViz, 12/8/25) - the Estimated Share Price is $79.54 with a Buy Price set at $39.77 or less.Read more
SEGRO's Revenue to Rise 14.7% Amidst Optimistic Growth Plans
1. Strategic Focus: Data Centers and "Power Banks" 1.1. Transition from "Powered Shell" to "Fully Fitted" Model In the past, SEGRO provided only the building shell and power connection for data centers, leaving the internal equipment (cooling, generators, server racks) to the tenant.Read more
PRME remains a long shot but publication in the New England Journal of Medicine helps.
PRME Medicine has just announced the publication of an important article in The New England Journal of Medicine. The article announces success in developing a new treatment using gene editing and stem cell therapy in clinical trials.Read more
This one is all about the tax benefits
I became attracted to this ETF because of it's high percentage of dividends that qualify as long-term, qualified dividends. I don't recall the exact percentage, but it's something in the neighborhood of 62% of dividends being qualified.Read more
